The Role of Neuropilin in Vascular and Tumor Biology

  • Michael Klagsbrun
  • Seiji Takashima
  • Roni Mamluk
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 515)

Abstract

Neuropilin-1 (NRP 1) and NRP2 are related transmembrane receptors that function as mediators of neuronal guidance and angiogenesis. NRPs bind members of the class 3 semaphorin family, regulators of neuronal guidance, and of the vascular endothelial growth factor (VEGF) family of angiogenesis factors. There is substantial evidence that NRPs serve as mediators of developmental and tumor angiogenesis. NRPs are expressed in endothelial cells (EC) and bind VEGF165. NRP1 is a co-receptor for VEGF receptor-2 (VEGFR2) that enhances the binding of VEGF165 to VEGFR2 and VEGF165-mediated chemotaxis. NRP1 expression is regulated in EC by tumor necrosis factor-α, the transcription factors dHAND and Ets- 1, and vascular injury. During avian blood vessel development NRP I is expressed only in arteries whereas NRP2 is expressed in veins. Transgenic mouse models demonstrate that NRP1 plays a critical role in embryonic vascular development. Overexpression of NRP 1 results in the formation of excess capillaries and hemorrhaging. NRP1 knockouts have defects in yolk sac, embryo and neuronal vascularization, and in development of large vessels in the heart. Tumor cells express NRPs and bind VEGF165. NRP1 upregulation is positively correlated with the progression of various tumors. Overexpression of NRP 1 in rat tumor cells results in enlarged tumors and substantially enhanced tumor angiogenesis. On the other hand, soluble NRP1 (sNRP 1) is an antagonist of tumor angiogenesis. Semaphorin 3A binds to EC and tumor cells. It also inhibits EC motility and capillary sprouting in vitro. VEGF165

Keywords

Permeability Migration Arthritis Ischemia Tyrosine 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Fujisawa H, Kitsukawa, T. Receptors for collapsin/semaphorins. Curr Opin Neurobiol 1998; 8:587–592.PubMedCrossRefGoogle Scholar
  2. 2.
    Neufeld G, Cohen T, Gengrinovitch S et al. Vascular endothelial growth factor (VEGF) and its receptors. FASEB J 1999; 13:9–22.PubMedGoogle Scholar
  3. 3.
    Shima D, Mailhos C. Vascular development biology: getting nervous. Curr Opin Genet Dev 2000; 10:536–542.PubMedCrossRefGoogle Scholar
  4. 4.
    Raper JA. Semaphorins and their receptors in vertebrates and invertebrates. Curr Opin Neurobiol 2000; 10:88–94.PubMedCrossRefGoogle Scholar
  5. 5.
    Miao HQ, Klagsbrun M. Neuropilin is a mediator of angiogenesis. Cancer Metastasis Rev 2000; 19:29–37.PubMedCrossRefGoogle Scholar
  6. 6.
    Soker S. Neuropilin in the midst of cell migration and retraction. Int J Oncol 2001; 33:433–437.Google Scholar
  7. 7.
    Takagi S, Kasuya Y, Shimizu M et al. Expression of a cell adhesion molecule, neuropilin, in the developing chick nervous system. Dev Biol 1995; 170:207–222.PubMedCrossRefGoogle Scholar
  8. 8.
    Kawakami A, Kitsukawa T, Takagi S et al. Developmentally regulated expression of a cell surface protein, neuropilin, in the mouse nervous system. J Neurobiol 1996; 29:1–17.PubMedCrossRefGoogle Scholar
  9. 9.
    Fujisawa H, Kitsukawa T, Kawakami A et al. Roles of a neuronal cell-surface molecule, neuropilin, in nerve fiber fasciculation and guidance. Cell Tissue Res 1997; 290:465–470.PubMedCrossRefGoogle Scholar
  10. 10.
    Kolodkin AL, Levengood DV, Rowe EG et al. Neuropilin is a semaphorin III receptor. Cell 1997; 90:753–762.PubMedCrossRefGoogle Scholar
  11. 11.
    Kitsukawa T, Shimono A, Kawakami A et al. Overexpression of a membrane protein, neuropilin, in chimeric mice causes anomalies in the cardiovascular system, nervous system and limbs. Development 1995; 121:4309–4318.PubMedGoogle Scholar
  12. 12.
    Soker S, Takashima S, Miao HQ et al. Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor. Cell 1998; 92:735–745.PubMedCrossRefGoogle Scholar
  13. 13.
    Gagnon ML, Bielenberg DR, Gechtman Z et al. Identification of a natural soluble neuropilin-1 that binds vascular endothelial growth factor: In vivo expression and antitumor activity. Proc Nati Acad Sci USA 2000; 97:2573–2578.CrossRefGoogle Scholar
  14. 14.
    Rossignol M, Gagnon ML, Klagsbrun M. Genomic organization of human neuropilin-1 and neuropilin-2 genes: identification and distribution of splice variants and soluble isoforms, Genomics 2000; 70:211–222.PubMedCrossRefGoogle Scholar
  15. 15.
    Pavelock K, Braas K, Ouafik L et al. Differential expression and regulation of the vascular endothelial growth factor receptors neuropilin-1 and neuropilin-2 in rat uterus. Endocrinology 2001; 142:613–622.PubMedCrossRefGoogle Scholar
  16. 16.
    Eickholt BJ, Mackenzie SL, Graham A et al. Evidence for collapsin-1 functioning in the control of neural crest migration in both trunk and hindbrain regions. Development 1999; 126:2181–2189.PubMedGoogle Scholar
  17. 17.
    Deckers MM, Karperien M, van der Bent C et al. Expression of vascular endothelial growth factors and their receptors during osteoblast differentiation. Endocrinology 2000; 141:1667–1674.PubMedCrossRefGoogle Scholar
  18. 18.
    Harper J, Gerstenfeld LC, Klagsbrun M. Neuropilin-1 expression in osteogenic cells: down-regulation during differentiation of osteoblasts into osteocytes. J Cell Biochem 2001; 81:82–92.PubMedCrossRefGoogle Scholar
  19. 19.
    Tordjman R, Ortega N, Coulombel L et al. Neuropilin-1 is expressed on bone marrow stromal cells: a novel interaction with hematopoietic cells? Blood 1999; 94:2301–2309.PubMedGoogle Scholar
  20. 20.
    Thomas S, Vanuystel J, Gruden G et al. Vascular endothelial growth factor receptors in human mesangium in vitro and in glomerular disease. J Am Soc Nephrol 2000; 11:1236–1243.PubMedGoogle Scholar
  21. 21.
    Cohen T, Gluzman-Poltorak Z, Brodzky A et al. Neuroendocrine cells along the digestive tract express neuropilin-2. Biochem Biophys Res Commun 2001; 284:395–403.PubMedCrossRefGoogle Scholar
  22. 22.
    Harper SJ, Xing CY, Whittle C et al. Expression of neuropilin-I by human glomerular epithelial cells in vitro and in vivo. Clin Sci 2001; 101:439–446.PubMedCrossRefGoogle Scholar
  23. 23.
    Cai H, Reed RR. Cloning and characterization of neuropilin-l-interacting protein: a PSD-95/ Dlg/ZO-1 domain-containing protein that interacts with the cytoplasmic domain of neuropilin-1. J Neurosci 1999; 19:6519–6527.PubMedGoogle Scholar
  24. 24.
    Rossignol M, Beggs AH, Pierce EA et al. Human neuropilin-1 and neuropilin-2 map to 10p12 and 2q34, respectively. Genomics 1999; 57:459–460.PubMedCrossRefGoogle Scholar
  25. 25.
    He Z, Tessier-Lavigne M. Neuropilin is a receptor for the axonal chemorepellent Semaphorin III. Cell 1997; 90:739–751.PubMedCrossRefGoogle Scholar
  26. 26.
    Chen H, Chedotal A, He Z et al. Neuropilin-2, a novel member of the neuropilin family, is a high affinity receptor for the semaphorins Sema E and Sema IV but not Sema III. Neuron 1997; 19:547–559.Google Scholar
  27. 27.
    Chen H, He Z, Bagri A et al. Semaphorin-neuropilin interactions underlying sympathetic axon responses to class III semaphorins. Neuron 1998; 21:1283–1290.PubMedCrossRefGoogle Scholar
  28. 28.
    Takahashi T, Nakamura F, Jin Z et al. Semaphorins A and E act as antagonists of neuropilin-I and agonists of neuropilin-2 receptors. Nat Neurosci 1998; 1:487–493.PubMedCrossRefGoogle Scholar
  29. 29.
    Giger RJ, Urquhart ER, Gillespie SK et al. Neuropilin-2 is a receptor for semaphorin IV: insight into the structural basis of receptor function and specificity. Neuron 1998; 21:1079–1092.PubMedCrossRefGoogle Scholar
  30. 30.
    Luo Y, Raible D, Raper JA. Collapsin: a protein in brain that induces the collapse and paralysis of neuronal growth cones. Cell 1993; 75:217–227.PubMedCrossRefGoogle Scholar
  31. 31.
    Marin O, Yaron A, Bargri A et al. Sorting of striatal and cortical interneurons regulated by semaphorin-neuropilin interactions. Science 2001; 293:872–875.PubMedCrossRefGoogle Scholar
  32. 32.
    Winberg ML, Noordermeer JN, Tamagnone L et al. Plexin A is a neuronal semaphorin receptor that controls axon guidance. Cell 1998; 95:903–916.PubMedCrossRefGoogle Scholar
  33. 33.
    Tamagnone L, Artigiani S, Chen H et al. Plexins are a large family of receptors for trans-membrane, secreted, and GPI-anchored semaphorins in vertebrates. Cell 1999; 99:71–80.PubMedCrossRefGoogle Scholar
  34. 34.
    Tamagnone L, Comoglio PM. Signaling by semaphorin receptors: cell guidance and beyond. Trends Cell Biol 2000; 10:377–383.PubMedCrossRefGoogle Scholar
  35. 35.
    Castellani V, Chedotal A, Schachne, M et al. Analysis of the LI-deficient mouse phenotype reveals cross-talk between Sema3A and LI signaling pathways in axonal guidance. Neuron 2000; 27:237–249.PubMedCrossRefGoogle Scholar
  36. 36.
    Ferrara N. Molecular and biological properties of vascular endothelial growth factor. J Mol Med 1999; 77:527–543.PubMedCrossRefGoogle Scholar
  37. 37.
    Dvorak HF, Nagy JA, Feng D et al. Vascular permeability factor/vascular endothelial growth factor and the significance of microvascular hyperpermeability in angiogenesis. Curt Top Microbiol Immunol 1999; 237:97–132.CrossRefGoogle Scholar
  38. 38.
    Soker S, Fidder H, Neufeld G et al. Characterization of novel vascular endothelial growth factor (VEGF) receptors on tumor cells that bind VEGF165 via its exon 7-encoded domain. J Biol Chem 1996; 271:5761–5767.PubMedCrossRefGoogle Scholar
  39. 39.
    Gluzman-Poltorak Z, Cohen T, Herzog Y et al. Neuropilin-2 is a receptor for the vascular endothelial growth factor (VEGF) forms VEGF-145 and VEGF-165. J Biol Chem 2000; 275:29922.PubMedCrossRefGoogle Scholar
  40. 40.
    Migdal M, Huppertz B, Tessler S et al. Neuropilin-1 is a placenta growth factor-2 receptor. J Biol Chem 1998; 273:22272–22278.PubMedCrossRefGoogle Scholar
  41. 41.
    Makinen T, Olofsson B, Karpanen T et al. Differential binding of vascular endothelial growth factor B splice and proteolytic isoforms to neuropilin-l. J Biol Chem 1999; 274:21217–21222.PubMedCrossRefGoogle Scholar
  42. 42.
    Wise LM, Veikkola T, Mercer AA et al. Vascular endothelial growth factor (VEGF)-like protein from orf virus NZ2 binds to VEGFR2 and neuropilin-1. Proc Natl Acad Sci USA 1999; 96:3071–3076.PubMedCrossRefGoogle Scholar
  43. 43.
    Savory LJ, Stacker SA, Fleming SB et al. Viral vascular endothelial growth factor plays a critical role in orf virus infection. J Virol 2000; 74:10699–10706.PubMedCrossRefGoogle Scholar
  44. 44.
    Karkkainen MJ, Saaristo A, Jussila L et al. A model for gene therapy of human hereditary lymphedema. Proc Natl Acad Sci USA 2001; 98:12677–12682.PubMedCrossRefGoogle Scholar
  45. 45.
    Fuh G, Garcia KC, de Vos AM. The interaction of neuropilin-1 with vascular endothelial growth factor and its receptor flt-1. J Biol Chem 2000; 275:26690–26695.PubMedGoogle Scholar
  46. 46.
    Whitaker GB, Limberg BJ, Rosenbaum JS. Vascular endothelial growth factor receptor-2 and neuropilin-1 form a receptor complex that is responsible for the differential signaling potency of VEGF(165) and VEGF(12l). J Biol Chem 2001; 276:25520–25531.PubMedCrossRefGoogle Scholar
  47. 47.
    Gluzman-Poltorak Z, Cohen T, Shibuya M et al. Vascular endothelial growth factor receptor-1 and neuropilin-2 form complexes. J Biol Chem 2001; 276:18688–18694.PubMedCrossRefGoogle Scholar
  48. 48.
    Miao HQ, Soker S, Feiner L et al. Neuropilin-1 mediates collapsin-1/semaphorin III inhibition of endothelial cell motility: functional competition of collapsin-1 and vascular endothelial growth factor-165. J Cell Biol 1999; 146:233–242.PubMedGoogle Scholar
  49. 49.
    Partanen TA, Makinen T, Arola J et al. Endothelial growth factor receptors in human fetal heart. Circulation 1999; 100:583–586.PubMedCrossRefGoogle Scholar
  50. 50.
    Robert B, Zhao X, Abrahamson DR. Coexpression of neuropilin-1, Flkl, and VEGF(164) in developing and mature mouse kidney glomeruli. Am I Physiol 2000; 279:F275–F282.Google Scholar
  51. 51.
    Ishida A, Murray J, Saito Y et al. Expression of vascular endothelial growth factor receptors in smooth muscle cells. J Cell Physiol 2001; 188:359–368.PubMedCrossRefGoogle Scholar
  52. 52.
    Adams RH, Wilkinson GA, Weiss C et al. Roles of ephrinB ligands and EphB recceptors in cardiovascular development: demarcation of arterial/venous domains, vascular morphogenesis, and sprouting angiogenesis. Genes Dev 1999; 13:295–306.PubMedCrossRefGoogle Scholar
  53. 53.
    Moyon D, Pardanaud L, Yuan L et al. Plasticity of endothelial cells during arterial-venous differentiation in the avian embryo. Development 2001; 128:3359–3370.PubMedGoogle Scholar
  54. 54.
    Herzog Y, Kalcheim C, Kahane N et al. Differential expression of neuropilin-1 and neuropilin-2 in arteries and veins. Mech Dev 2001; 109:115–119.PubMedCrossRefGoogle Scholar
  55. 55.
    Stalmans I, Ng YS, Rohan R et al. Arteriolar and venular patterning in retinas of mice selectively expressing VEGF isoforms. J Clin Invest 2002; 109:327–336.PubMedGoogle Scholar
  56. 56.
    Giraudo E, Primo L, Audero E et al. Tumor necrosis factor-alpha regulates expression of vascular endothelial growth factor receptor-2 and of its co-receptor neuropilin-I in human vascular endothelial cells. J Biol Chem 1998; 273:22128–22135.PubMedCrossRefGoogle Scholar
  57. 57.
    Yamagishi H, Olson EN, Srivastava D. The basic helix-loop-helix transcription factor, dHAND, is required for vascular development. J Clin Invest 2000; 105:261–270.PubMedCrossRefGoogle Scholar
  58. 58.
    Sato Y, Abe M, Tanaka K et al. Signal transduction and transcriptional regulation of angiogenesis. Adv Exp Med Biol 2000; 476:109–115.PubMedCrossRefGoogle Scholar
  59. 59.
    Teruyama K, Abe M, Nakano T et al. Neurophilin-1 is a downstream target of transcription factor Ets-1 in human umbilical vein endothelial cells. FEBS Lett 2001; 504:1–4.PubMedCrossRefGoogle Scholar
  60. 60.
    Wernert N, Raes MB, Lassalle P et al. c-etsl proto-oncogene is a transcription factor expressed in endothelial cells during tumor vascularization and other forms of angiogenesis in humans. Am I Pathol 1992; 140:119–127.Google Scholar
  61. 61.
    Kitsukawa T, Shimizu M, Sanbo M et al. Neuropilin-semaphorin III/D-mediated chemorepulsive signals play a crucial role in peripheral nerve projection in mice. Neuron 1997; 19:995–1005.PubMedCrossRefGoogle Scholar
  62. 62.
    Kawasaki T, Kitsukawa T, Bekku Y et al. A requirement for neuropilin-1 in embryonic vessel formation. Development 1999; 126:4895–4902.PubMedGoogle Scholar
  63. 63.
    Giger RJ, Cloutier JF, Sahay A et al. Neuropilin-2 is required in vivo for selective axon guidance responses to secreted semaphorins. Neuron 2000; 25:29–41.PubMedCrossRefGoogle Scholar
  64. 64.
    Chen H, Bagri A, Zupicich JA et al. Neuropilin-2 regulates the development of selective cranial and sensory nerves and hippocampal mossy fiber projections. Neuron 2000; 25:43–56.PubMedCrossRefGoogle Scholar
  65. 65.
    Takashima S, Kitakaze M, Asakura M et al. Targeting of both mouse neuropilin-1 and neuropilin-2 genes severely impairs developmental yolk sac and embryonic angiogenesis. Proc Natl Acad Sci USA 2002; 99:(in press).Google Scholar
  66. 66.
    Yamada Y, Takakura N, Yasue H et al. Exogenous clustered neuropilin 1 enhances vasculogenesis and angiogenesis. Blood 2001; 97:1671–1678.PubMedCrossRefGoogle Scholar
  67. 67.
    Bagnard D, Vaillant C, Khuth ST et al. Semaphorin 3A-vascular endothelial growth factor-165 balance mediates migration and apoptosis of neural progenitor cells by the recruitment of shared receptor. J Neurosci 2001; 21:3332–3341.PubMedGoogle Scholar
  68. 68.
    Sondell M, Sundler F, Kanje M. Vascular endothelial growth factor is a neurotrophic factor which stimulates axonal outgrowth through the flk-I receptor. Eur J Neurosci 2000; 12:4243–4254.PubMedCrossRefGoogle Scholar
  69. 69.
    Jin KL, Mao XO, Greenberg DA. Vascular endothelial growth factor: direct neuroprotective effect in in vitro ischemia. Proc Natl Acad Sci USA 2000; 97:10242–10247.PubMedCrossRefGoogle Scholar
  70. 70.
    Oosthuyse B, Moons L, Storkebaum E et al. Deletion of the hypoxia-response element in the vascular endothelial growth factor promoter causes motor neuron degeneration. Nat Genet 2001; 28:131–138.PubMedCrossRefGoogle Scholar
  71. 71.
    Shirvan A, Shina R, Ziv I et al. Induction of neuronal apoptosis by Semaphorin3A-derived peptide. Brain Res Mol Brain Res 2000; 83:81–93.PubMedCrossRefGoogle Scholar
  72. 72.
    Latil A, Bieche I, Pesche S et al. VEGF overexpression in clinically localized prostate tumors and neuropilin-I overexpression in metastatic forms. Int J Cancer 2000; 89:167–171.PubMedCrossRefGoogle Scholar
  73. 73.
    Lacal PM, Failla CM, Pagani E et al. Human melanoma cells secrete and respond to placenta growth factor and vascular endothelial growth factor. J Invest Dermatol 2000; 115:1000–1007.PubMedCrossRefGoogle Scholar
  74. 74.
    Ding H, Wu X, Roncari L et al. Expression and regulation of neuropilin-1 in human astrocytomas. Int J Cancer 2000; 88:584–592.PubMedCrossRefGoogle Scholar
  75. 75.
    Handa A, Tokunaga T, Tsuchida T et al. Neuropilin-2 expression affects the increased vascularization and is a prognostic factor in osteosarcoma. Int J Oncol 2000; 17:291–295.PubMedGoogle Scholar
  76. 76.
    Banerjee SK, Zoubine MN, Tran TM et al. Overexpression of vascular endothelial growth factorl64 and its co-receptor neuropilin-1 in estrogen-induced rat pituitary tumors and GH3 rat pituitary tumor cells. Int J Oncol 2000; 16:253–260.PubMedGoogle Scholar
  77. 77.
    Miao HQ, Lee P, Lin H et al. Neuropilin-1 expression by tumor cells promotes tumor angiogenesis and progression. FASEB J 2000; 14:2532–9.PubMedCrossRefGoogle Scholar
  78. 78.
    Benjamin LE, Keshet E. Conditional switching of vascular endothelial growth factor (VEGF) expression in tumors: induction of endothelial cell shedding and regression of hemangioblastoma-like vessels by VEGF withdrawal. Proc Natl Acad Sci USA 1997; 94:8761–8766.PubMedCrossRefGoogle Scholar
  79. 79.
    Bachelder R, Crago A, Chung J et al. Vascular endothelial growth factor is an autocrine survival factor for neuropilin-expressing breast carcinoma cells. Cancer Res 2001; 61:5736–5740.PubMedGoogle Scholar
  80. 80.
    Xiang RH, Hensel CH, Garcia DK et al. Isolation of the human semaphorin III/F gene (SEMA3F) at chromosome 3p21, a region deleted in lung cancer. Genomics 1996; 32:39–48.PubMedCrossRefGoogle Scholar
  81. 81.
    Roche J, Boldog F, Robinson M et al. Distinct 3p21.3 deletions in lung cancer and identification of a new human semaphorin. Oncogene 1996; 12:1289–1297.PubMedGoogle Scholar
  82. 82.
    Sekido Y, Bader S, Latif F et al. Human semaphorins A(V) and IV reside in the 3p21.3 small cell lung cancer deletion region and demonstrate distinct expression patterns. Proc Natl Acad Sci USA 1996; 93:4120–4125.PubMedCrossRefGoogle Scholar
  83. 83.
    Brambilla E, Constantin B, Drabkin H et al. Semaphorin SEMA3F localization in malignant human lung and cell lines: A suggested role in cell adhesion and cell migration. Am J Pathol 2000; 156:939–950.PubMedCrossRefGoogle Scholar
  84. 84.
    Tomizawa Y, Sekido Y, Kondo M et al. Inhibition of lung cancer cell growth and induction of apoptosis after reexpression of 3p21.3 candidate tumor suppressor gene SEMA3B. Proc Natl Acad Sci USA 2001; 98:13954–13959.PubMedCrossRefGoogle Scholar
  85. 85.
    Tse C, Xiang RH, Bracht T et al. Human Semaphorin 3B (SEMA3B) Located at Chromosome 3p21.3 Suppresses Tumor Formation in an Adenocarcinoma Cell Line. Cancer Res 2002; 62:542–546.PubMedGoogle Scholar
  86. 86.
    Martin-Satue M, Blanco J. Identification of semaphorin E gene expression in metastatic human lung adenocarcinoma cells by mRNA differential display. J Surg Oncol Suppl 1999; 72:18–23.CrossRefGoogle Scholar
  87. 87.
    Fujisawa H, Takagi S, Hirata T. Growth-associated expression of a membrane protein, neuropilin, in Xenopus optic nerve fibers. Dev Neurosci 1995; 17:343–349.PubMedCrossRefGoogle Scholar
  88. 88.
    Zhang ZG, Tsang W, Zhang L et al. Up-regulation of neuropilin-1 in neovasculature after focal cerebral ischemia in the adult rat. J Cereb Blood Flow Metab 2001; 21:541–549.PubMedCrossRefGoogle Scholar
  89. 89.
    Ishihama H, Ohbayashi M, Kurosawa N et al. Colocalization of neuropilin-1 and Flk-1 in retinal neovascularization in a mouse model of retinopathy. Invest Ophthalmol Vis Sci 2001; 42:1172–1178.PubMedGoogle Scholar
  90. 90.
    Ishida S, Shinoda K, Kawashima S et al. Coexpression of VEGF receptors VEGF-R2 and neuropilin-1 in proliferative diabetic retinopathy. Invest Ophthalmol Vis Sci 2000; 41:1649–1656.PubMedGoogle Scholar
  91. 91.
    Murohara T, Asahara T, Silver M et al. Nitric oxide synthase modulates angiogenesis in response to tissue ischemia. J Clin Invest 1998; 101:2567–2578.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2002

Authors and Affiliations

  • Michael Klagsbrun
    • 1
    • 2
  • Seiji Takashima
    • 3
  • Roni Mamluk
    • 1
  1. 1.Departments of Surgical ResearchChildren’s Hospital and Harvard Medical SchoolBoston
  2. 2.Departments of PathologyChildren’s Hospital and Harvard Medical SchoolBoston
  3. 3.Department of Internal Medicine and TherapeuticsOsaka University Graduate School of MedicineSuita OsakaJapan

Personalised recommendations